Health & Environment
AI Collaboration Targets 'Undruggable' Protein in Pancreatic Cancer Treatment
The Indian Express1h
THE BRIEF
1
Sravathi AI and the Mayo Clinic have successfully identified a new drug candidate targeting the GIPC1 protein, previously considered 'undruggable' in pancreatic cancer.
2
The AI-driven research model analyzed thousands of protein structures to pinpoint the specific binding site, significantly accelerating the drug discovery timeline.
3
Clinical trials for the new candidate are expected to begin in early 2027, offering a potential breakthrough for patients with advanced-stage pancreatic tumors.